The University of Chicago Header Logo

Connection

Christopher Daugherty to Prognosis

Back to Details
This is a "connection" page, showing publications Christopher Daugherty has written about Prognosis.
Christopher Daugherty
Connection Strength
0.615
Prognosis
  1. What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure. J Clin Oncol. 2008 Dec 20; 26(36):5988-93.
    View in: PubMed
    Score: 0.159
  2. 'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003 Apr; 17(2):142-68.
    View in: PubMed
    Score: 0.108
  3. Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials. J Oncol Pract. 2018 06; 14(6):e357-e367.
    View in: PubMed
    Score: 0.077
  4. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer. PM R. 2012 Feb; 4(2):96-108.
    View in: PubMed
    Score: 0.050
  5. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007 Feb 10; 25(5):548-54.
    View in: PubMed
    Score: 0.035
  6. Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psychooncology. 2005 Feb; 14(2):135-46.
    View in: PubMed
    Score: 0.031
  7. Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Invest. 2004; 22(1):123-31.
    View in: PubMed
    Score: 0.028
  8. Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2003 May 01; 21(9 Suppl):42s-45s.
    View in: PubMed
    Score: 0.027
  9. Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2002 Jun 01; 20(11):2752-5.
    View in: PubMed
    Score: 0.025
  10. Informed consent, the cancer patient, and phase I clinical trials. Cancer Treat Res. 2000; 102:77-89.
    View in: PubMed
    Score: 0.022
  11. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Adv. 2018 01 23; 2(2):146-150.
    View in: PubMed
    Score: 0.019
  12. High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leuk Lymphoma. 2012 Mar; 53(3):445-50.
    View in: PubMed
    Score: 0.012
  13. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2007 Dec; 40(11):1027-32.
    View in: PubMed
    Score: 0.009
  14. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006 Sep; 12(9):954-64.
    View in: PubMed
    Score: 0.009
  15. Prognostic factors for functional outcome of total knee replacement: a prospective study. J Gerontol A Biol Sci Med Sci. 1996 Jul; 51(4):M152-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.